| Description | Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody derived from mouse and human sources, designed to target the Ebola virus glycoprotein (EBOV-GP) [1]. |
| molecular weight | N/A |
| CAS | 1792982-57-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |